Filing Details
- Accession Number:
- 0001237899-11-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-22 16:08:17
- Reporting Period:
- 2011-03-21
- Filing Date:
- 2011-03-22
- Accepted Time:
- 2011-03-22 16:08:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403178 | S Douglas Mccorkle | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller And Asst Treasur | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-21 | 3,750 | $20.32 | 3,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-21 | 3,750 | $40.02 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-03-21 | 6,850 | $20.32 | 6,850 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-21 | 6,850 | $40.02 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-03-21 | 3,750 | $0.00 | 3,750 | $20.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-03-21 | 6,850 | $0.00 | 6,850 | $20.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-12-18 | No | 4 | M | Direct | |
| 0 | 2016-12-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,120 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold a total of 10,600 shares of Company stock on March 21, 2011 at prices ranging from $40.00 to 40.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 21, 2011 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.
Billionaire Hedge Funds
